sharla gelfand
The MODEL-AD consortium consisting of a Center at Indiana University School of Medicine, The Jackson Laboratory, Sage Bionetworks and the University of Pittsburgh School of Medicine, and a Center at the University of California Irvine has been established by the National Institute on Aging to:
Screening the Optimal Pharmaceutical for Alzheimer’s Disease ( STOP-AD ) is a program that offers preclinical screening of compounds through the MODEL-AD Preclinical Testing Core.
AD Knowledge Portal
sharla gelfand